The ATP site of protein kinases as target for drug development: from natural compounds to gleevec.
Yosef
Y
Granot
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D001549:Benzamides; D001665:Binding Sites; D015195:Drug Design; D049673:History, 20th Century; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000737:chemistry / Q000266:history; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000266:history* / Q000378:metabolism; D011743:Pyrimidines / Q000737:chemistry / Q000266:history; D015398:Signal Transduction
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D000255:Adenosine Triphosphate; D011494:Protein Kinases; D000251:Adenosine Triphosphatases